Published Online
on April 8, 2004

A more recent version of this article appeared on May 1, 2004

This Article Full Text (PDF) All Versions of this Article: 35/5/1121    most recent 01.STR.0000126481.79085.47v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Streifler, J. Y. Search for Related Content PubMed PubMed Citation Articles by Streifler, J. Y. Related Collections Other Stroke Treatment - Medical

Statins, Stroke Outcome, and Stroke Prevention: When Should We Start Treatment?

Jonathan Y. Streifler MD

Neurology Department, Rabin Medical Center, Petach Tikva and Tel Aviv University, Israel

This article has been cited by other articles:

				A. Arboix Potential Impact of Sulfonylureas in the Outcome of Type 2 Diabetic Patients With Ischemic Stroke Stroke, September 1, 2007; 38(9): 2413 - 2414. [Full Text] [PDF]